These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Physicochemical characterization and antitumor activity in vitro of a selenium polysaccharide from Pleurotus ostreatus.
    Author: Zhang Y, Zhang Z, Liu H, Wang D, Wang J, Deng Z, Li T, He Y, Yang Y, Zhong S.
    Journal: Int J Biol Macromol; 2020 Dec 15; 165(Pt B):2934-2946. PubMed ID: 33115648.
    Abstract:
    Selenium-enriched polysaccharides have been gaining great attention for their antitumor activity in recent years. In this study, a novel selenium polysaccharide fraction (Se-POP-3) produced by Pleurotus ostreatus was characterized and its antitumor activity explored at cellular level. Results showed that Se-POP-3 has 25.9 μg/g of selenium, an average molecular weight of 16,106 Da, and is mainly composed of mannose, glucose and galactose with a molar ratio of 1.7:49.6:2.4. Spectra analysis revealed Se-POP-3 as a pyranopolysaccharide linked by α-glycoside bonds in the main chain, and selenium may occur in the form of COSe and SeO. A single sphere of Se-POP-3 has 50-60 nm in aqueous solution, even though it can agglomerate to form larger spherical structures. In vitro experiments with cancer and normal cell lines showed that Se-POP-3 can induce apoptosis and inhibit migration of cancer cells. Potential anticancer mechanism is that Se-POP-3 can disrupt the Bax/Bcl-2 protein ratio and inhibit the epithelial-to-mesenchymal transition (EMT) in cancer cells. Se-POP-3 showed no significant effect on the growth of normal cell lines. Se-POP-3 showed great potential as a broad-spectrum antitumor agent and dietary supplement.
    [Abstract] [Full Text] [Related] [New Search]